John M. Climaco
Equibles does not estimate personal net worth.
About John M. Climaco
Earlier roles on record: CEO and Board Member at CNS Pharmaceuticals, Inc. (CNSP) until December 16, 2025. The proxy statement of CNS Pharmaceuticals, Inc. reports total compensation of $1,103,680 for John M. Climaco in fiscal 2024, including a base salary of $525,000. Disclosed compensation is on record for 7 fiscal years.
Affiliation history
-
Start not stated–2025-12-16
-
Start not stated–2025-12-16
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | CNS Pharmaceuticals, Inc. (CNSP) | CEO | $525,000 | $1,103,680 |
| 2023 | CNS Pharmaceuticals, Inc. (CNSP) | CEO | $525,000 | $624,348 |
| 2022 | CNS Pharmaceuticals, Inc. (CNSP) | CEO | $525,000 | $827,928 |
| 2021 | CNS Pharmaceuticals, Inc. (CNSP) | CEO | $525,000 | $845,940 |
| 2020 | CNS Pharmaceuticals, Inc. (CNSP) | CEO | $440,000 | $1,572,908 |
| 2019 | CNS Pharmaceuticals, Inc. (CNSP) | CEO | $213,867 | $1,229,304 |
| 2018 | CNS Pharmaceuticals, Inc. (CNSP) | CEO | $150,000 | $164,300 |
Recent activity
No call appearances or filed executive changes recorded yet.